title: [The treatment of solid tumors with monoclonal antibodies].
abstract: Patients with B-cell lymphomas, gastrointestinal tumors and melanomas were treated in pilot and phase-I clinical studies with monoclonal antibodies directed to tumor-associated antigens in recent years. Side effects of this new treatment approach were minor. Tumor regressions were observed in all three groups of tumors.
authors.affiliation: I. Medizinische Klinik und Poliklinik, Universität Mainz.
authors.forename: W G
authors.initials: WG
authors.lastname: Dippold
authors.forename: K H
authors.initials: KH
authors.lastname: Meyer zum Büschenfelde
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005770:Gastrointestinal Neoplasms / Q000628:therapy*; D006801:Humans; D008223:Lymphoma / Q000628:therapy*; D008545:Melanoma / Q000628:therapy*
chemical_list: D000911:Antibodies, Monoclonal
vernacular_title: Behandlung solider Tumoren mit monoklonalen Antikörpern.